Skip to main content

Table 1 Study variables

From: Effectiveness of topiramate for tobacco dependence in patients with depression; a randomised, controlled trial

Instrument

Assessment area

Applied by

Time(s) of assessments

Sampling form

Age, sex, inclusion/exclusion criteria

Family doctor

Baseline

Sociodemographic data form

Age, sex, marital status, educational level, Socio-economic group (28), occupation

Research assistant

Baseline

MINI psychiatric interview, depression and tobacco dependence modules (27)

Psychiatric diagnosis

Research psychiatrist

Baseline

Zung Self-Rating Depression Scale (22)

Severity of depression

Research assistant

Baseline and possible relapses

State of change (23)

State of change

Research assistant

Baseline

Self-declared abstinence

Tobacco abstinence

Research assistant

Baseline and all follow-up sessions*

Minnesota tobacco abstinence symptoms (24)

Tobacco abstinence

Research assistant

Baseline and all follow-up sessions*

Expired air carbon monoxide levels (25)

Tobacco abstinence

Research assistant

Baseline and all follow-up sessions*

Cotinine levels in saliva

Tobacco abstinence

Research assistant

Baseline and all follow-up sessions*

Fagerström test for Nicotine Dependence (29)

Tobacco dependence

Research assistant

Baseline and many follow-up sessions**

State-Trait Anxiety Inventory (STAI) (30)

Anxiety

Research assistant

Baseline and many follow-up sessions**

Plutchik Impulsivity Scale (31)

Impulsivity

Research assistant

Baseline and many follow-up sessions**

Visual analog scale

Efficacy self-perception

Research assistant

Baseline and many follow-up sessions**

Medical record

Pharmacological side-effect events

Research assistant

Baseline and many follow-up sessions**

  1. *All follow-up sessions: D (cessation day) -1, D + 1, weeks 1, 2, 3, 4, 6, 8, 10 and 13, and months 4, 5, 6, 8, 10 and 12 (16 sessions in total) **Many follow-up sessions: weeks 1, 4, 8 and months 4, 6, 8, 10, 12.